Vyome Holdings - HIND Accounting Capitalization

The historical price action of Vyome Holdings Inc (HIND) is subject to the influence of geopolitical fragmentation, which complicates the procurement of biomaterials and global testing. The current figure stands at 0.01. The business relies on partnerships with medical centers to implement Lap-Band systems and obesity medications. Simultaneously, Vyome Holdings Inc (HIND) is conducting preclinical trials of new molecules against resistant forms of acne, currently remaining in the phase of scheduled laboratory research.

HIND - Vyome Therapeutics Book Capitalization over the range 08/16/2025 - 10/31/2026

The dynamics of Vyome Holdings Inc (HIND) net asset value allow for a real-time assessment of the actual capital value minus liabilities, eliminating the time lag of standard reporting for financial stability analysis. For Vyome Holdings Inc, this indicator reflects management's ability to accumulate resources for the commercialization of Lap-Band systems and the development of anti-obesity drugs, confirming the resource base for expansion within the minimally invasive medicine sector.

Competitor analysis for Vyome Holdings Inc

ARGX (argenx BVBA) - Accounting Capitalization|BNTX: Book Capitalization|Accounting Capitalization ABVX|Company Book Value ADMA Biologics, Inc.|Protagonist Therapeutics, Inc. - Net Asset Value|Book Capitalization IMVT|KNSA (Kiniksa Corp) - Accounting Value of Company|Book Capitalization GRFS (Grifols, S.A.)|Book Capitalization adaptivebiotech.com ADPT|CLDX - Company Book Value|Accounting Value of Company AUPH (Aurinia Pharmaceuticals Inc)|BioCryst Pharmaceuticals Inc (BCRX) - Company Book Value|Company Net Assets Vera Corp|DNTH (Dianthus Therapeutics) - Book Capitalization|Book Capitalization pharvaris.com|Company Net Assets ABCL (AbCellera Bio)|TRML (Tourmaline Bio Inc) - Accounting Value of Company|Book Capitalization PGEN (Intrexon)|Book Valuation of Business Pharming Corp (PHAR)|NKTR - Company Book Value|upstreambio.com (UPB) - Company Net Assets|Zenas Biopharma (ZBIO) - Company Book Value|Company Net Assets Immunome Inc|Company Net Assets GOSS|Book Capitalization KalVista Corp|Company Book Value Septerna Inc (SEPN)|pieris.com - Accounting Capitalization|Book Capitalization SVRA (Savara)|Rigel Pharma (RIGL) - Total Stockholders' Equity|ANAB: Company Net Assets|ATXS: Company Book Value|ENGN (enGene Holdings Inc.) - Company Net Assets|Total Stockholders' Equity rapt.com (RAPT)|Company Book Value Aerovate Therapeutics, Inc.|Total Stockholders' Equity Aclaris Therapeutics Inc. ACRS|Company Book Value Kyverna (KYTX)|Company Net Assets Tiziana Life Sciences, Ltd. TLSA|Book Capitalization CABA (Cabaletta Bio, Inc.)|ventyxbio.com (VTYX) - Total Stockholders' Equity|THTX: Company Net Assets|Accounting Value of Company AVTX (Avalo Therapeutics, Inc.)|ELDN: Book Capitalization|Agenus, Inc - Accounting Value of Company|Company Book Value Climb Bio Inc|Total Stockholders' Equity zurabio.com ZURA|Company Book Value aTyr Pharma (ATYR)|Company Book Value ADAG (adagene.com)|Book Capitalization IMA (Ikena Oncology)|STTK: Accounting Capitalization|Equillium Bio - Book Capitalization|Book Valuation of Business Connect Biopharma CNTB|immunic-therapeutics.com (IMUX) - Company Book Value|Accounting Capitalization ATRA|IFRX (InflaRx NV) - Book Capitalization|XFOR - Book Value of Business|Company Book Value Adicet Bio (ACET)|Book Valuation of Business celularity.com|INmune Bio - Company Net Assets|Accounting Value of Company BRNS|Kezar Life Sciences, Inc - Book Capitalization|Book Valuation of Business SAB Biotherapeutics Inc SABS|Akari Therapeutics (AKTX) - Company Book Value|Accounting Capitalization ENLV|QTTB (Q32 Bio Inc) - Book Capitalization|Company Net Assets GeoVax Labs (GOVX)|Book Capitalization EDSA|IBIO (iBio Corporation) - Accounting Value of Company|Book Capitalization CARM (Carisma Therapeutics Inc.)|Book Valuation of Business xtlbio.com (XTLB)|BOLT - Company Book Value|HCWB (HCW Biologics Inc.) - Accounting Capitalization|APVO: Book Capitalization|Accounting Capitalization AIM|Company Book Value Aditxt Inc.|gribio.com - Net Asset Value|Book Capitalization XRTX|REVB (Revelation Biosciences Inc) - Accounting Value of Company|Book Capitalization INDP (Indaptus)|Book Capitalization BiondVax Pharmaceuticals SCNI|CALI - Company Book Value|Accounting Value of Company AFMD (Affimed)|allakos.com (ALLK) - Company Book Value|Company Net Assets HOOKIPA Pharma|IGMS (IGM Biosciences Inc.) - Book Capitalization|Book Capitalization iTeos Pharma|Company Net Assets OCEA (Ocean Biomedical, Inc.)|TCBP (tcbiopharm.com) - Accounting Value of Company|Book Capitalization THRD (Third Harmonic Bio, Inc.)